Prevalence of Bordetella pertussis and Bordetella parapertussis infections in Tunisian hospitalized infants: Results of a 4-year prospective study

Diagnostic Microbiology and Infectious Disease

Volumn 72, Issue 4, 2012, Pages 303-317

  Zouari, Asma ^a   Smaoui, Hanen ^a   Brun, Delphine ^b,c   Njamkepo, Elisabeth ^b,c   Sghaier, Soufien ^d   Zouari, Emna ^e   Félix, Renaud ^f   Menif, Khaled ^a   Ben Jaballah, Najla ^a   Guiso, Nicole ^b,c   Kechrid, Amel ^a  

^a CHILDREN S HOSPITAL   (Tunisia)

^b INSTITUT PASTEUR   (France)

^c CNRS   (France)

^d University Tunis El Manar   (Tunisia)

^e UNIVERSITY OF CARTHAGE   (Tunisia)

^f Social Security   (France)

Author keywords

Bordetella; Infants; Laboratory diagnosis; Pertussis; Tunisia

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAMASE; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; ERYTHROMYCIN; IMMUNOGLOBULIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AGE DISTRIBUTION; APNEA; ARTICLE; ARTIFICIAL VENTILATION; ATELECTASIS; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BLOOD SAMPLING; BORDETELLA BRONCHISEPTICA INFECTION; BORDETELLA PARAPERTUSSIS INFECTION; CONTROLLED STUDY; CYANOSIS; DIAGNOSTIC ACCURACY; ETHNIC GROUP; FEMALE; GENE AMPLIFICATION; HUMAN; INFANT; INTUBATION; LYMPHOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; NASOPHARYNGEAL ASPIRATION; NOSE SMEAR; PERTUSSIS; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; PTX GENE; PULMONARY HYPERTENSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECA GENE; RELIABILITY; SEIZURE; SEX DIFFERENCE; TUNISIAN;

ADULT; BORDETELLA INFECTIONS; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; CHILD, PRESCHOOL; DNA, BACTERIAL; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NASOPHARYNX; PERTUSSIS TOXIN; PREVALENCE; PROSPECTIVE STUDIES; PUBLIC HEALTH; REAL-TIME POLYMERASE CHAIN REACTION; TUNISIA; WHOOPING COUGH;

EID: 84858334177     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.01.002     Document Type: Article

References (83)

1. André P., Caro V., Njamkepo E., Wendelboe A.M., Van Rie A., Guiso N. Comparison of serological and real-time PCR assays to diagnose Bordetella pertussis infection in 2007. J. Clin. Microbiol. 2008, 46:1672-1677.
2. Antila M., He Q., de Jong C., Aarts I., Verbakel H., Bruisten S., Keller S., Haanperä M., Mäkinen J., Eerola E., Viljanen M.K., Mertsola J., van der Zee A. Bordetella holmesii DNA is not detected in nasopharyngeal swabs from Finnish and Dutch patients with suspected pertussis. J. Med. Microbiol. 2006, 55:1043-1051.
3. Bamberger E., Lahat N., Gershtein V., Gershtein R., Benilevi D., Shapiro S., Kassis I., Rubin L., Srugo I. Diagnosing pertussis: the role of polymerase chain reaction. Isr. Med. Assoc. J. 2005, 7:351-354.
4. Baptista P.N., Magalhães V.S., Rodrigues L.C. The role of adults in household outbreaks of pertussis. Int. J. Infect. Dis. 2010, 14:e111-e114.
5. Baron S., Njamkepo E., Grimprel E., Begue P., Desenclos J.C., Drucker J., Guiso N. Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. Pediatr. Infect. Dis. J. 1998, 17:412-418.
6. Bokhari H., Said F., Syed M.A., Mughal A., Kazi Y.F., Heuvelman K., Mooi F.R. Whooping cough in Pakistan: Bordetella pertussis vs Bordetella parapertussis in 2005-2009. Scand. J. Infect. Dis. 2011, 43:818-820.
7. Bonmarin I., Levy-Bruhl D., Baron S., Guiso N., Njamkepo E., Caro V., Renacoq Pertussis surveillance in French hospitals: results from a 10 year period. Euro Surveill. 2007, Epub ahead of print.
8. Bouchez V., Brun D., Cantinelli T., Dore G., Njamkepo E., Guiso N. First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin. Vaccine 2009, 27:6034-6041.
9. Bouchez V., Caro V., Levillain E., Guigon G., Guiso N. Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination. PLoS One 2008, 3:e2437.
10. Bryant K.A., Humbaugh K., Brothers K., Wright J., Pascual F.B., Moran J., Murphy T.V. Measures to control an outbreak of pertussis in a neonatal intermediate care nursery after exposure to a healthcare worker. Infect. Control Hosp. Epidemiol. 2006, 27:541-545.
11. California Department of Public Health (CDPH) B. parapertussis infection: public health recommendations 2011, [Online] Available at:. http://www.cdph.ca.gov/HealthInfo/discond/Documents/BParaPertussisInfectionPublicHealthRecommendations201107.pdf.
12. Caro V., Guiso N., Alberti C., Liguori S., Burucoa C., Couetdic G., Doucet-Populaire F., Ferroni A., Papin-Gibaud S., Grattard F., Réglier-Poupet H., Raymond J., Soler C., Bouchet S., Charreau S., Couzon B., Leymarie I., Tavares N., Choux M., Bingen E., Bonacorsi S. Proficiency program for real-time PCR diagnosis of Bordetella pertussis infections in French hospital laboratories and at the French National Reference Center for Whooping Cough and Other Bordetelloses. J. Clin. Microbiol. 2009, 47:3197-3203.
13. Chan E.L., Antonishyn N., McDonald R., Maksymiw T., Pieroni P., Nagle E., Horsman G.B. The use of TaqMan PCR assay for detection of Bordetella pertussis infection from clinical specimens. Arch. Pathol. Lab. Med. 2002, 126:173-176.
14. Cherry J.D. The present and future control of pertussis. Clin. Infect. Dis. 2010, 51:663-667.
15. Cloud J.L., Hymas W.C., Turlak A., Croft A., Reischl U., Daly J.A., Carroll K.C. Description of a multiplex Bordetella pertussis and Bordetella parapertussis LightCycler PCR assay with inhibition control. Diagn Microbiol Infect Dis 2003, 46:189-195.
16. Crowcroft N.S., Booy R., Harrison T., Spicer L., Britto J., Mok Q., Heath P., Murdoch I., Zambon M., George R., Miller E. Severe and unrecognized: pertussis in UK infants. Arch. Dis. Child. 2003, 88:802-806.
17. de Greeff S.C., Mooi F.R., Westerhof A., Verbakel J.M., Peeters M.F., Heuvelman C.J., Notermans D.W., Elvers L.H., Schellekens J.F., de Melker H.E. Pertussis disease burden in the household: how to protect young infants. Clin. Infect. Dis. 2010, 50:1339-1345.
18. Direction de santé de soin de base, ministère de la Santé publique de la Tunisie (2009) Rapportd'activité.
19. Dragsted D.M., Dohn B., Madsen J., Jensen J.S. Comparison of culture and PCR for detection of Bordetella pertussis and Bordetella parapertussis under routine laboratory conditions. J. Med. Microbiol. 2004, 53:749-754.
20. Farizo K.M., Cochi S.L., Zell E.R., Brink E.W., Wassilak S.G., Patriarca P.A. Epidemiological features of pertussis in the United States, 1980-1989. Clin. Infect. Dis. 1992, 14:708-719.
21. Farrell D.J., McKeon M., Daggard G., Loeffelholz M.J., Thompson C.J., Mukkur T.K. Rapid-cycle PCR method to detect Bordetella pertussis that fulfills all consensus recommendations for use of PCR in diagnosis of pertussis. J. Clin. Microbiol. 2000, 38:4499-4502.
22. Favre D., Cryz S.J., Viret J.F. Cloning of the recA gene of Bordetella pertussis and characterization of its product. Biochimie 1991, 73:235-244.
23. Floret D., Groupe de pathologie infectieuse pédiatrique, Groupe francophone de réanimation et d'urgence pédiatrique Les décès par infection bactérienne communautaire. Enquête dans les services de réanimation pédiatrique français. Arch. Pediatr. 2001, 8:705s-711s.
24. Fry N.K., Duncan J., Wagner K., Tzivra O., Doshi N., Litt D.J., Crowcroft N., Miller E., George R.C., Harrison T.G. Role of PCR in the diagnosis of pertussis infection in infants: 5 years' experience of provision of a same-day real-time PCR service in England and Wales from 2002 to 2007. J. Med. Microbiol. 2009, 58:1023-1029.
25. Fry N.K., Tzivra O., Duncan J., Doshi N., Harrison T.G. Consensus real-time PCR assay for Bordetella pertussis including an internal process control provides, specific diagnosis rapid turnaround time, high diagnostic yield and enhanced surveillance. 14th European Congress of Clinical Microbiology and Infectious Diseases, Prague, Czech Republic 1-4 May 2004. Clin. Microbiol. Infect. 2004, 10(Suppl 3):7. [Abstract].
26. Fry N.K., Tzivra O., Li Y.T., McNiff A., Doshi N., Maple P.A., Crowcroft N.S., Miller E., George R.C., Harrison T.G. Laboratory diagnosis of pertussis infections: the role of PCR and serology. J. Med. Microbiol. 2004, 53:519-525.
27. Ghanaie R.M., Karimi A., Sadeghi H., Esteghamti A., Falah F., Armin S., Fahimzad A., Shamshiri A., Kahbazi M., Shiva F. Sensitivity and specificity of the World Health Organization pertussis clinical case definition. Int. J. Infect. Dis. 2010, 14:e1072-e1075.
28. Goh A., Chong C.Y., Tee N., Loo L.H., Yeo J.G., Chan Y.H. Pertussis-an under-diagnosed disease with high morbidity in Singapore children. Vaccine 2011, 29:2503-2507.
29. Greenberg D., Bamberger E., Ben-Shimol S., Gershtein R., Golan D., Srugo I. Pertussis is under diagnosed in infants hospitalized with lower respiratory tract infection in the pediatric intensive care unit. Med. Sci. Monit. 2007, 13:CR475-CR480.
30. Grimprel E., Bégué P., Anjak I., Njamkepo E., François P., Guiso N. Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France. Clin. Diagn. Lab. Immunol. 1996, 3:93-97.
31. Grimprel E., Njamkepo E., Bégué P., Guiso N. Rapid diagnosis of pertussis in young infants: comparison of culture, PCR, and infant's and mother's serology. Clin. Diagn. Lab. Immunol. 1997, 4:723-726.
32. Guiso N., Berbers G., Fry N.K., He Q., Riffelmann M., Wirsing von König C.H. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur. J. Clin. Microbiol. Infect. Dis. 2011, 30:307-312. EU Pertstrain group.
33. Guiso N., Liese J., Plotkin S. The Global Pertussis Initiative: meeting report from the fourth regional roundtable meeting, France, April 14-15, 2010. Hum. Vaccin. 2011, 7:481-488.
34. Guthrie J.L., Robertson A.V., Tang P., Jamieson F., Drews S.J. Novel duplex real-time PCR assay detects Bordetella holmesii in specimens from patients with Pertussis-like symptoms in Ontario, Canada. J. Clin. Microbiol. 2010, 48:1435-1437.
35. Hallander H.O., Reizenstein E., Renemar B., Rasmuson G., Mardin L., Olin P. Comparison of nasopharyngeal aspirates with swabs for culture of Bordetella pertussis. J. Clin. Microbiol. 1993, 31:50-52.
36. He Q., Mertsola J. Factors contributing to pertussis resurgence. Future Microbiol. 2008, 3:329-339.
37. Heininger U., Kleemann W.J., Cherry J.D. A controlled study of the relationship between Bordetella pertussis infections and sudden unexpected deaths among German infants. Pediatrics 2004, 114:e9-e15. Sudden Infant Death Syndrome Study Group.
38. Heininger U. Update on pertussis in children. Expert Rev. Anti. Infect. Ther. 2010, 8:163-173.
39. Hewlett E.L., Edwards K.M. Clinical practice. Pertussis-not just for kids. N. Engl. J. Med. 2005, 352:1215-1222.
40. Iwata S., Aoyama T., Goto A., Iwai H., Sato Y., Akita H., Murase Y., Oikawa T., Iwata T., Kusano S. Mixed outbreak of Bordetella pertussis and Bordetella parapertussis in an apartment house. Dev. Biol. Stand. 1991, 73:333-341.
41. Kapaskelis A.M., Vouloumanou E.K., Rafailidis P.I., Hatzopoulou P., Nikita D., Falagas M.E. High prevalence of antibody titers against Bordetella pertussis in an adult population with prolonged cough. Respir. Med. 2008, 102:1586-1591.
42. Knorr L., Fox J.D., Tilley P.A., Ahmed-Bentley J. Evaluation of real-time PCR for diagnosis of Bordetella pertussis infection. BMC Infect. Dis. 2006, 6:62.
43. Koidl C., Bozic M., Burmeister A., Hess M., Marth E., Kessler H.H. Detection and differentiation of Bordetella spp. by real-time PCR. J. Clin. Microbiol. 2007, 45:347-350.
44. Kösters K., Reischl U., Schmetz J., Riffelmann M., Wirsing von König C.H. Real-time LightCycler PCR for detection and discrimination of Bordetella pertussis and Bordetella parapertussis. J. Clin. Microbiol. 2002, 40:1719-1722.
45. Kösters K., Riffelmann M., Wirsing von König C.H. Evaluation of a real-time PCR assay for detection of Bordetella pertussis and B. parapertussis in clinical samples. J. Med. Microbiol. 2001, 50:436-440.
46. Lin P.Y., Chiu C.H., Wang Y.H., Su L.H., Chia J.H., Huang Y.C., Chung P.W., Wu T.L., Lin T.Y. Bordetella pertussis infection in northern Taiwan, 1997-2001. J. Microbiol. Immunol. Infect. 2004, 37:288-294.
47. Mastrantonio P., Stefanelli P., Giuliano M., Herrera Rojas Y., Ciofi degli Atti M., Anemona A., Tozzi A.E. Bordetella parapertussis infection in children: epidemiology, clinical symptoms, and molecular characteristics of isolates. J. Clin. Microbiol. 1998, 36:999-1002.
48. Mattoo S., Cherry J.D. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 2005, 18:326-382.
49. Meade B.D., Bollen A. Recommendations for use of the polymerase chain reaction in the diagnosis of Bordetella pertussis infections. J. Med. Microbiol. 1994, 41:51-55.
50. Ménard A., Lehours P., Sarlangue J., Bébéar C., Mégraud F., de Barbeyrac B. Development of a real-time PCR for the identification of Bordetella pertussis and Bordetella parapertussis. Clin. Microbiol. Infect. 2007, 13:419-423.
51. Mertsola J. Mixed outbreak of Bordetella pertussis and Bordetella parapertussis infection in Finland. Eur. J. Clin. Microbiol. 1985, 4:123-128.
52. Mikelova L.K., Halperin S.A., Scheifele D., Smith B., Ford-Jones E., Vaudry W., Jadavji T., Law B., Moore D., Members of the Immunization Monitoring Program, Active (IMPACT) Predictors of death in infants hospitalized with pertussis: a case-control study of 16 pertussis deaths in Canada. J. Pediatr. 2003, 143:576-581.
53. Mooi F.R., de Greeff S.C. The case for maternal vaccination against pertussis. Lancet Infect. Dis. 2007, 7:614-624.
54. Mooi F.R., He Q., Guiso N. Phylogeny, evolution and epidemiology of Bordetella. Bordetella Molecular Microbiology 2007, 17-45. Horizon Bioscience, 32 Hewitts Lane, Wymondham, Norfolk NR18 OJA, UK. C. Locht (Ed.).
55. Moraga F., Roca J., Méndez C., Rodrigo C., Pineda V., Martinez A., Baraibar R., Boronat M. Epidemiology and surveillance of pertussis among infants in Catalonia, Spain, during 1997-2001. Pediatr. Infect. Dis. J. 2005, 24:510-513. TOSCA Study Group.
56. Murphy T.V., Syed S.B., Holman R.C., Haberling D.L., Singleton R.J., Steiner C.A., Paisano E.L., Cheek J.E. Pertussis-associated hospitalizations in American Indian and Alaska Native infants. J. Pediatr. 2008, 152:839-843.
57. Muyldermans G., Soetens O., Antoine M., Bruisten S., Vincart B., Doucet-Populaire F., Fry N.K., Olcén P., Scheftel J.M., Senterre J.M., van der Zee A., Riffelmann M., Piérard D., Lauwers S. External quality assessment for molecular detection of Bordetella pertussis in European laboratories. J. Clin. Microbiol. 2005, 43:30-35.
58. Papenburg J., Fontela P. What is the significance of a high cycle threshold positive IS481 PCR for Bordetella pertussis?. Pediatr. Infect. Dis. J. 2009, 28:1143.
59. Paterson J.M., Sheppeard V. Nosocomial pertussis infection of infants: still a risk in 2009. Commun. Dis. Intell. 2009, 34:440-443.
60. Pierce C., Klein N., Peters M. Is leukocytosis a predictor of mortality in severe pertussis infection?. Intensive Care Med. 2000, 26:1512-1514.
61. Probert W.S., Ely J., Schrader K., Atwell J., Nossoff A., Kwan S. Identification and evaluation of new target sequences for specific detection of Bordetella pertussis by real-time PCR. J. Clin. Microbiol. 2008, 46:3228-3231.
62. Qin X., Galanakis E., Martin E.T., Englund J.A. Multitarget PCR for diagnosis of pertussis and its clinical implications. J. Clin. Microbiol. 2007, 45:506-511.
63. Reischl U., Lehn N., Sanden G.N., Loeffelholz M.J. Real-time PCR assay targeting IS481 of Bordetella pertussis and molecular basis for detecting Bordetella holmesii. J. Clin. Microbiol. 2001, 39:1963-1966.
64. Riffelmann M., von König C.H.W., Caro V., Guiso N. Nucleic acid amplification tests for diagnosis of Bordetella infections. J. Clin. Microbiol. 2005, 43:4925-4929. for the Pertussis PCR Consensus Group.
65. Sawal M., Cohen M., Irazuzta J.E., Kumar R., Kirton C., Brundler M.A., Evans C.A., Wilson J.A., Raffeeq P., Azaz A., Rotta A.T., Vora A., Vohra A., Abboud P., Mirkin L.D., Cooper M., Dishop M.K., Graf J.M., Petros A., Klonin H. Fulminant pertussis: a multi-center study with new insights into the clinico-pathological mechanisms. Pediatr. Pulmonol. 2009, 44:970-980.
66. Shakib J.H., Wyman L., Gesteland P.H., Staes C.J., Bennion D.W., Byington C.L. Should the pertussis case definition for public health reporting be refined?. J. Public Health Manag. Pract. 2009, 15:479-484.
67. Simondon F., Iteman I., Preziosi M.P., Yam A., Guiso N. Evaluation of an immunoglobulin G enzyme-linked immunosorbent assay for pertussis toxin and filamentous hemagglutinin in diagnosis of pertussis in Senegal. Clin. Diagn. Lab. Immunol. 1998, 5:130-134.
68. Stefanelli P., Mastrantonio P., Hausman S.Z., Giuliano M., Burns D.L. Molecular characterization of two Bordetella bronchiseptica strains isolated from children with coughs. J. Clin. Microbiol. 1997, 35:1550-1555.
69. Tanaka M., Vitek C.R., Pascual F.B., Bisgard K.M., Tate J.E., Murphy T.V. Trends in pertussis among infants in the United States, 1980-1999. JAMA 2003, 290:2968-2975.
70. Tatti K.M., Wu K.H., Tondella M.L., Cassiday P.K., Cortese M.M., Wilkins P.P., Sanden G.N. Development and evaluation of dual-target real-time polymerase chain reaction assays to detect Bordetella spp. Diagn. Microbiol. Infect. Dis. 2008, 61:264-272.
71. Templeton K.E., Scheltinga S.A., van der Zee A., Diederen B.M., van Kruijssen A.M., Goossens H., Kuijper E., Claas E.C. Evaluation of real-time PCR for detection of and discrimination between Bordetella pertussis, Bordetella parapertussis, and Bordetella holmesii for clinical diagnosis. J. Clin. Microbiol. 2003, 41:4121-4126.
72. Tozzi A.E., Celentano L.P., Ciofi degli Atti M.L., Salmaso S. Diagnosis and management of pertussis. CMAJ 2005, 172:509-515.
73. Tozzi A.E., Ravà L., Ciofi degli Atti M.L., Salmaso S. Clinical presentation of pertussis in unvaccinated and vaccinated children in the first six years of life. Pediatrics 2003, 112:1069-1075. Progetto Pertosse Working Group.
74. van der Zee A., Agterberg C., van Agterveld M., Peeters M., Mooi F.R. Characterization of IS1001, an insertion sequence element of Bordetella parapertussis. J. Bacteriol. 1993, 175:141-147.
75. Versteegh F.G.A., Schellekens J.F., Nagelkerke A.F., Roord J.J. Laboratory-confirmed reinfections with Bordetella pertussis. Acta Paediatr. 2002, 91:95-97.
76. Vitek C.R., Pascual F.B., Baughman A.L., Murphy T.V. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr. Infect. Dis. J. 2003, 22:628-634.
77. Wendelboe A.M., Njamkepo E., Bourillon A., Floret D.D., Gaudelus J., Gerber M., Grimprel E., Greenberg D., Halperin S., Liese J., Muñoz-Rivas F., Teyssou R., Guiso N., Van Rie A. Transmission of Bordetella pertussis to young infants. Pediatr. Infect. Dis. J. 2007, 26:293-299. Infant Pertussis Study Group.
78. Wendelboe A.M., Van Rie A., Salmaso S., Englund J.A. Duration of immunity against pertussis after natural infection or vaccination. Pediatr. Infect. Dis. J. 2005, 24:S58-S61.
79. WHO WHO-recommended standards for surveillance of selected vaccine-preventable diseases Vaccines and Biologicals [Online]. Available at:. http://www.who.int/immunization_monitoring/diseases/pertussis_surveillance/en/index.html.
80. Worthington Z.E., Van Rooijen N., Carbonetti N.H. Enhancement of Bordetella parapertussis infection by Bordetella pertussis in mixed infection of the respiratory tract. FEMS Immunol. Med. Microbiol. 2011, 63:119-128.
81. Zouari A., Smaoui H., Bousnina S., Menif K., Ben Jaballah N., Kechrid A. The new health legacy: when pertussis becomes a heritage transmitted from mothers to infants. J. Med. Microbiol. 2011, 60:1546-1549.
82. Zouari A., Smaoui H., Kechrid A. The diagnosis of pertussis: which method to choose?. Crit. Rev. Microbiol. 2011, Epub ahead of print.
83. Zouari A., Touati A., Smaoui H., Brun D., Kasdaghli K., Menif K., Ben Jaballah N., Ben Hassen Essia, Guiso N., Kechrid A. Dual infection with Bordetella pertussis and Mycoplasma pneumoniae in three infants: case reports. Infection 2011, Epub ahead of print.